NIR-II-Accelerated 2D-on-2D Silicene/MOF Heterointerfaces Disrupt Tumor Redox Homeostasis for Targeted Ferroptosis
Molecular Pharmaceutics · 02.11.2026 · 23 (11) · 5718-5734
DOI: 10.1021/acs.molpharmaceut.6c00816 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmaceutics, online erschienen am 09.10.2026. Verfasst von Hui Xu und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry and Chemical Engineering, Shanxi Normal University, Taiyuan030002, China. Hauptthemen laut MEDLINE: Ferroptosis. Die Arbeit nennt 72 Literaturangaben. Gefördert von: Scientific and Technological Projects of Datong City, the National Natural Science Foundation of China, the Fundamental Research Program of Shanxi Province.
Abstract (Originalsprache)
Catalytic ferroptosis therapy provides an attractive approach for tumor treatment, but its practical efficacy is often limited by insufficient reaction kinetics and the strong redox buffering capacity of the tumor microenvironment. Herein, we report an interface-engineered 2D-on-2D catalytic nanoplatform, SNs/FTC@Apt-P (SFTCP), constructed by integrating silicene nanosheets with an ultrathin Fe−Cu metal−organic framework and further functionalized with a PD-L1 aptamer for tumor targeting. The silicene/Fe−Cu metal−organic framework heterointerface offers abundant exposed catalytic sites and facilitates interfacial electron transfer, improving Fenton-like catalytic activity under biologically relevant conditions. At the biointerface, Fe3+/Cu2+ bimetallic centers consume intracellular glutathione (GSH) and weaken the xCT/GSH/GPX4 antioxidant defense pathway, thereby reducing the ability of tumor cells to eliminate lipid peroxides. Under NIR-II irradiation, SFTCP generates localized photothermal stimulation that acts as an external kinetic accelerator to further enhance catalytic oxidative stress. This interface-mediated and photothermally amplified process promotes lipid peroxide accumulation and induces ferroptotic tumor cell death. In vivo, aptamer-mediated targeting combined with NIR−II−augmented catalysis increases intratumoral lipid peroxidation and achieves 87% tumor growth inhibition with favorable biosafety. This work demonstrates an applied interface-engineering strategy for constructing catalytic nanomaterials that integrate redox regulation, photothermal activation, and ferroptosis-based tumor therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Chemistry and Chemical Engineering, Shanxi Normal University, Taiyuan030002, China.
- Shanxi Provincial Key Laboratory of Chemical Biosensing, School of Chemistry and Chemical Engineering, Shanxi Datong University, Datong037009, China.
- School of Agriculture and Life Science, Shanxi Datong University, Datong037009, China.
ORCID-Profile: Yunfeng Bai, Feng Feng
Förderung
- Scientific and Technological Projects of Datong City
- the National Natural Science Foundation of China
- the Fundamental Research Program of Shanxi Province
Zitieren
APA
Xu, H., Zhang, R., Zhao, L., Bai, Y., & Feng, F. (2026). NIR-II-Accelerated 2D-on-2D Silicene/MOF Heterointerfaces Disrupt Tumor Redox Homeostasis for Targeted Ferroptosis. Molecular Pharmaceutics, 23(11), 5718-5734. https://doi.org/10.1021/acs.molpharmaceut.6c00816
Vancouver
Xu H, Zhang R, Zhao L, Bai Y, Feng F. NIR-II-Accelerated 2D-on-2D Silicene/MOF Heterointerfaces Disrupt Tumor Redox Homeostasis for Targeted Ferroptosis. Molecular Pharmaceutics. 2026;23(11):5718-5734. doi:10.1021/acs.molpharmaceut.6c00816
BibTeX
@article{Xu2026,
author = {Xu, Hui and Zhang, Rong and Zhao, Lu and Bai, Yunfeng and Feng, Feng},
title = {NIR-II-Accelerated 2D-on-2D Silicene/MOF Heterointerfaces Disrupt Tumor Redox Homeostasis for Targeted Ferroptosis},
journal = {Molecular Pharmaceutics},
year = {2026},
volume = {23},
number = {11},
pages = {5718--5734},
doi = {10.1021/acs.molpharmaceut.6c00816}
}
EUVIMED